MOTS-C
Mitochondrial peptide
MOT-C is a mitochondrial-support peptide offered in a 40mg vial for provider-directed longevity care.
Important Research Notice
Research use only. Not for human consumption. This product is intended solely for laboratory research and educational applications. It is not designed for use in the diagnosis, treatment, cure, or prevention of any disease or medical condition. By purchasing this product, you acknowledge that this product is intended for research use only and agree to use it in accordance with all applicable laws and regulations.
People also buy
CJC-1295 (without DAC)
Growth hormone secretagogue peptide
CJC-1295 + Ipamorelin
Peptide blend
DSIP
Sleep support peptide
Epithalon
Longevity peptide
GHK-Cu
Copper peptide injectable
GLOW
Skin and wellness peptide blend
IGF-1 LR3
Growth factor peptide
Ipamorelin
Growth hormone releasing peptide
References
- MOTS-C - Peptide Center guide
- MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitationFrontiers in endocrinology, 2023
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistanceCell metabolism, 2015
- Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 DeubiquitinationAdvanced science (Weinheim, Baden-Wurttemberg, Germany), 2024
- The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitusPharmacological research, 2022
- MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genesRedox biology, 2025
- MOTS-c Functionally Prevents Metabolic DisordersMetabolites, 2023